Hypertension is a leading factor for heart disease, which causes more than 600,000 deaths annually

The number of people in the U.S. with hypertension continues to grow and along with that so does the risk of heart disease, which is the leading cause of death in America. There are more than 119 million Americans who suffer from high blood pressure, according to the U.S. Department of Health and Human Services.

People at risk are encouraged to be proactive about heart health and learn about the risk factors for high blood pressure. Only about 25% of people with hypertension have their condition under control, according to the Centers for Disease Control¹ and the Mayo Clinic lists home monitoring as a key factor in controlling blood pressure.

As American Heart Month winds down, Smart Meter, the leading supplier of cellular remote patient monitoring (RPM) solutions™, would like to encourage providers who care for people with hypertension to help their patients take control of their blood pressure by self-monitoring with an easy-to-use cellular-RPM device that sends the reading immediately to the physician.

In the 2024 National Hypertension Survey, 56% of those surveyed said that if they knew their results were being sent to their provider, they would test more consistently. That is an increase from 53% in the 2023 National Hypertension Survey. Also in the 2024 Survey, 54% said that an RPM program would help them better manage their blood pressure between doctor visits.

According to American Heart Association research² “real-time monitoring programs can reduce systolic blood pressure (SBP) and diastolic blood pressure (DBP) significantly, compared to traditional self-monitoring. This can lower the incidence of hypertension-related acute events, cutting costs of hospital stays and ER visits.” In one study³ of home monitoring 25% of patients were able to stop using hypertensive drugs.

“Any resource that aids or encourages hypertension patients to self monitor is incredibly valuable in the efforts to control the disease,” said Dr. Bill Lewis, a member of the CHQI Telemedicine Standards and Medical Advisory Board and Chair of the Telemedicine Accreditation Committee. “By using a remote patient monitoring (RPM) system with cellular-enabled devices that send readings immediately to a provider, patients know their test results are being viewed and tracked regularly.”

With Smart Meter’s proprietary cellular-connected iBloodPressure^® systems, the measurement is transmitted instantly to the patient’s physician through our exclusive private data network that ensures reliability, security, and privacy every time. Because all our iBloodPressure monitors provide easy, one-button operation, patients feel more comfortable testing on a regular basis, providing physicians with more data to make care decisions.

“The ability to track key factors that can lead to heart disease is now easier than ever with our iBloodPressure systems,” said Casey Pittock, Smart Meter’s CEO. “Our cellular technology means that the patient isn’t required to do anything after the test. We have seen firsthand the positive impact on patient outcomes when our iBloodPressure monitors are used with an RPM program.”

About Smart Meter, LLC

Smart Meter is the number one trusted supplier of cellular remote patient Monitoring (RPM) solutions. We empower a nationwide network of SmartPartners^TM who are working directly with healthcare providers to transform patient care. Millions of vital health data readings are reliably delivered across our platform to enable real-time, better-informed health care. Our proprietary patient-friendly, cellular FDA-registered monitoring devices are connected to an exclusive AT&T 4/5G network to ensure an engaging patient experience for improved adherence. For more information, visit SmartMeterRPM.com

¹ Facts About Hypertension | cdc.gov

² remote-patient-monitoring-guidance-2019.pdf (heart.org)

³ Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial - PubMed (nih.gov)

View source version on businesswire.com: https://www.businesswire.com/news/home/20240228712849/en/